TORONTO, Jan. 11, 2019 /CNW/ - Pure Global Cannabis Inc.
(TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the "Company" or "Pure Global")
an integrated, growth-oriented life sciences and consumer products
cannabis company, through its subsidiary PureSinse Inc.
("PureSinse"), is excited to announce that Health Canada has issued
PureSinse a Sales License under the Cannabis Act.
Eligible and pre-registered Canadian medical patients can soon
select from two dozen premium cannabis products offered by
PureSinse, via its newly launched eCommerce website at
PureSinse.com. The Company is committed to supporting medical
cannabis patients by emphasizing the quality of and access to the
products they need. The Company anticipates growing to 70 SKUs
(stock-keeping units) by mid-2019, including adding extracted oil
products, and vape pens.
PureSinse continues to demonstrate commitment to the medical
community by leading one of the largest real-world evidence-based
clinical studies in conjunction with the Appletree Medical Group
and one of the largest Clinical Research Organizations in the
world. The clinical data, which will be collected from thousands of
patients, will provide necessary data points for guidance in the
therapeutic benefits of specific cannabis strains for commonly
reported medical symptoms. This evidence will guide PureSinse's
future pharmaceutical product and consumer product development
plans and provide the medical community with published peer
reviewed observational data on the efficacy of medical cannabis for
a range of conditions.
As part of the Sales Licence, the Company can also sell products
into the adult-legal consumer market through provincially licensed
retailers, for which it is launching uniquely curated lines of
consumer products tailored to specific market segments.
"This is a significant milestone for us and something we have
been vigorously preparing for over the last several months," said
Malay Panchal, CEO of Pure Global. "We feel the medical community
has been hugely underserviced with poor patient and physician
education, and product offerings, areas we hope to be trail blazers
in and make a significant contribution to in 2019," added Mr.
Panchal.
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSX.V:PURE; OTC:PRCNF; FRA:1QS) is an
innovation-based cannabis Company led by experienced pharma,
biotechnology, horticultural, and consumer packaged goods (CPG)
experts. The Company's wholly owned subsidiary, PureSinse Inc., is
a licensed producer under the Cannabis Act. The Company's
Brampton campus houses facilities
for vertically farmed cultivation, R&D, extraction,
manufacturing, and distribution. PURE will produce branded and
white-labeled cannabis products for the medical, pharmaceutical,
wellness, health & beauty, natural health, food & beverage,
and recreational legal markets with uniquely formulated and
purified concentrates. The Company is using the Canadian market as
a springboard to develop and manufacture GMP-compliant cannabis
products for international sale and distribution with a goal to
become one of the most trusted premium international cannabis
brands.
To register to Pure Global's mailing list, please
visit www.pureglobal.com. Follow @pureglobalcanna
on Twitter and Facebook and @pureglobalcannabis
on Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains
certain forward-looking statements, including, but not limited to,
statements about Pure Global's future plans and intentions.
Wherever possible, words such as "may", "will", "should", "could",
"expect", "plan", "intend", "anticipate", "believe", "estimate",
"predict" or "potential" or the negative or other variations of
these words, or similar words or phrases, have been used to
identify these forward-looking statements. These statements reflect
management's current beliefs and are based on information currently
available to management as at the date hereof.
Forward-looking statements involve significant risk,
uncertainties and assumptions. Many factors could cause actual
results, performance or achievements to differ materially from the
results discussed or implied in the forward-looking statements.
These factors should be considered carefully and readers should not
place undue reliance on the forward-looking statements. Although
the forward-looking statements contained in this news release are
based upon what management believes to be reasonable assumptions,
Pure Global cannot assure readers that actual results will be
consistent with these forward-looking statements. These
forward-looking statements are made as of the date of this news
release, and Pure Global assumes no obligation to update or revise
them to reflect new events or circumstances, except as required by
law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this
release.
To register to Pure Global's mailing list, please visit
www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook
and @pureglobalcannabis on Instagram.
SOURCE Pure Global Cannabis Inc.
